Effects of Milk-based Drinks on Gut Microbiome, Sleep and Cardiometabolic Markers
Launched by SHEFFIELD HALLAM UNIVERSITY · Jul 9, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how drinking kefir, a milk-based fermented drink, might affect gut health, sleep quality, heart health, thinking skills, and mood in adults who have trouble sleeping. The researchers want to see if drinking kefir every day can improve the balance of bacteria in the gut, help people sleep better, lower certain fats and cholesterol in the blood, and positively influence brain function and mood. They will also look at how kefir affects blood flow, inflammation, and the immune system.
To take part, you need to be between 40 and 70 years old, have poor sleep as measured by a simple questionnaire, and have a body weight that falls within a specific range. Participants will be asked to drink 250 ml of either kefir or regular milk every day for 4 weeks, then take a break for 4 weeks before switching to the other drink. During the study, you’ll visit the lab four times for tests and assessments. People who are allergic to milk, pregnant, breastfeeding, have certain gut problems, or can’t attend the visits won’t be able to join. This study is currently looking for volunteers who meet these criteria.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 40-70 years old
- • Suffer with poor sleep (measured using the PIttsburg Sleep Quality Index with a score \> 5)
- • BMI in range of 25-35 kg/m2
- • Willingness to consume each study drink daily for 4 weeks and attend the laboratory on 4 separate occasions
- • For women: Medication in the form of contraception or HRT providing these have not been modified 3 months prior to the first study day
- Exclusion Criteria:
- • Intolerance or allergy to milk-based products
- • Pregnancy/breastfeeding
- • Insufficient English language skills to complete all study questionnaires and perform the cognitive tests
- • Gastrointestinal disorders
- • Inability to attend the laboratory due to travel/mobility difficulties
About Sheffield Hallam University
Sheffield Hallam University is a leading institution in the United Kingdom, recognized for its commitment to advancing research and innovation in the health sciences. With a strong emphasis on interdisciplinary collaboration, the university conducts rigorous clinical trials aimed at improving patient outcomes and enhancing healthcare practices. Its research teams are composed of experienced professionals dedicated to ethical standards and scientific integrity, ensuring that trials not only contribute to academic knowledge but also address real-world health challenges. Through its state-of-the-art facilities and partnerships with healthcare organizations, Sheffield Hallam University strives to translate research findings into practical applications that benefit communities and inform clinical practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leeds, West Yorkshire, United Kingdom
Sheffield, , United Kingdom
Patients applied
Trial Officials
Tony Lynn, PhD
Principal Investigator
Sheffield Hallam University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported